Reducing Disparities in the Quality of Advance Care Planning for Older Adults
NCT ID: NCT03516994
Last Updated: 2024-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
790 participants
INTERVENTIONAL
2018-08-01
2024-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community Health Worker Based Intervention to Improve Palliative Care
NCT05407844
UC Health Care Planning Study
NCT04012749
The Responses Study
NCT04445896
End-of-Life Care for African Americans
NCT02320123
Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study
NCT04290364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will include 800 seriously or chronically ill community-dwelling older adults (equal number of African Americans and whites) and their caregivers from 10 primary care practices at five medical centers in the Deep South. Eligible patients include those with cancer, advanced heart disease, advanced lung disease, end-stage kidney disease, cirrhosis, diabetes with severe complications, recurrent hospitalizations, or difficulty with basic activities of daily living. For each enrolled patient, one caregiver who is likely to assist the patient with healthcare decisions is also eligible to participate.
The goals of the study are to:
* Compare the effectiveness of two approaches to increasing formal advance care planning (completing written documents like living wills, health care proxies, medical orders for life-sustaining treatments, or other advance directives) and informal advance care planning (having conversations with doctors, family, friends, and others about wishes for future healthcare) for African Americans and for Whites.
* Determine which intervention is most effective in reducing differences between African Americans and Whites in rates of advance care planning.
* Determine whether the effectiveness of the advance care planning approach differs based on whether the person assisting with advance care planning is of the same or different race as the patient.
Administered by community health workers, the two advance care planning approaches which will be compared are:
* Patient-driven approach which includes a Five Wishes Form (advance directive written in easy to understand language)
* Structured approach with an advance care planning conversation led by a trained person using Respecting Choices (First Step) conversation guide.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Structured Advance Care Planning
In the structured advance care planning approach, patients will participate in a 60 to 90 minute facilitated advance care planning conversation with a trained person using Respecting Choices (First Steps) guide and will receive a state advance directive form. The advance care planning facilitator will follow-up as needed after the session to answer additional questions.
Respecting Choices First Steps
Advance Care Planning Approach
Patient Driven Advance Care Planning
In the patient-driven advance care planning approach, patients receive a Five Wishes Form (easy to understand advance directive written in plain language), a state advance directive form, and at least two follow-up phone calls with an advance care planning contact who will answer questions.
Five Wishes Form
Advance Care Planning Approach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Respecting Choices First Steps
Advance Care Planning Approach
Five Wishes Form
Advance Care Planning Approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 65 or greater
* English-speaking
* residing in non-institutional setting
* cognitively able to participate in advance care planning
* Serious or chronic illness including: metastatic cancer; end stage renal disease; advanced liver disease, heart disease or lung disease; amyotrophic lateral sclerosis, severe Parkinson's disease; 2 or more unplanned hospitalizations in the last year; requiring assistance with any basic activity of daily living
* Serious illness based on the following: Clinician answers "no" to the surprise question: "Would you be surprised if this person died in the next 12 months?"
Exclusion Criteria
* diagnosis of dementia or unable to consent
* documented advance care plan (living will, health care proxy, MOST form, provider note)
* current or prior use of hospice
* current or prior use of non-hospice palliative care except inpatient palliative care consultation
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kimberly Johnson, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Emory University
Atlanta, Georgia, United States
University of South Carolina
Columbia, South Carolina, United States
University of Texas Southwestern
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OLC-1609-36381
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Pro00091633
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.